Copyright
©The Author(s) 2015.
World J Stem Cells. Dec 26, 2015; 7(11): 1222-1232
Published online Dec 26, 2015. doi: 10.4252/wjsc.v7.i11.1222
Published online Dec 26, 2015. doi: 10.4252/wjsc.v7.i11.1222
Parameter | Score points | |||
0 | 1 | 2 | 3 | |
Primary site | Gonadal | Extragonadal | - | Mediastinal non-seminoma |
Prior response | CR/PRm- | PRm+/SD | PD | - |
PFI, mo | > 3 | ≥ 3 | - | - |
AFP salvage | Normal | ≤ 1000 | > 1000 | |
HCG salvage | ≤ 1000 | > 1000 | - | - |
LBB | No | Yes | - | - |
Score sum (0-10) Regroup into categories: (0) = 0; (1 or 2) = 1; (3 or 4) = 2; (5 or more) = 3 Add histology points: Seminoma = -1; Non-seminoma or mixed = 1 Final prognostic score: -1 = Very low risk; 0 = Low risk; 1 = Intermediate risk; 2 = High risk; 3 = Very high risk |
- Citation: Popovic L, Matovina-Brko G, Popovic M, Petrovic D, Cvetanovic A, Vukojevic J, Jovanovic D. High dose chemotherapy with stem cell support in the treatment of testicular cancer. World J Stem Cells 2015; 7(11): 1222-1232
- URL: https://www.wjgnet.com/1948-0210/full/v7/i11/1222.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v7.i11.1222